GB202112782D0 - Compound separated from root bark of ginkgo biloba and use thereof - Google Patents

Compound separated from root bark of ginkgo biloba and use thereof

Info

Publication number
GB202112782D0
GB202112782D0 GBGB2112782.4A GB202112782A GB202112782D0 GB 202112782 D0 GB202112782 D0 GB 202112782D0 GB 202112782 A GB202112782 A GB 202112782A GB 202112782 D0 GB202112782 D0 GB 202112782D0
Authority
GB
United Kingdom
Prior art keywords
ginkgo biloba
root bark
compound separated
compound
separated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB2112782.4A
Other versions
GB2597145A (en
GB2597145B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Conba Pharm Co Ltd
ZHEJIANG CONBA PHARMACEUTICAL CO Ltd
Original Assignee
Zhejiang Conba Pharm Co Ltd
ZHEJIANG CONBA PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Conba Pharm Co Ltd, ZHEJIANG CONBA PHARMACEUTICAL CO Ltd filed Critical Zhejiang Conba Pharm Co Ltd
Publication of GB202112782D0 publication Critical patent/GB202112782D0/en
Publication of GB2597145A publication Critical patent/GB2597145A/en
Application granted granted Critical
Publication of GB2597145B publication Critical patent/GB2597145B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
GB2112782.4A 2019-03-29 2019-10-28 Compound separated from root bark of Ginkgo biloba and use thereof Active GB2597145B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910249522.8A CN111747914B (en) 2019-03-29 2019-03-29 Compound separated from ginkgo root bark and application thereof
PCT/CN2019/113565 WO2020199568A1 (en) 2019-03-29 2019-10-28 Compound separated from root bark of ginkgo biloba and use thereof

Publications (3)

Publication Number Publication Date
GB202112782D0 true GB202112782D0 (en) 2021-10-20
GB2597145A GB2597145A (en) 2022-01-19
GB2597145B GB2597145B (en) 2022-06-15

Family

ID=72664811

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2112782.4A Active GB2597145B (en) 2019-03-29 2019-10-28 Compound separated from root bark of Ginkgo biloba and use thereof

Country Status (3)

Country Link
CN (1) CN111747914B (en)
GB (1) GB2597145B (en)
WO (1) WO2020199568A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113899840B (en) * 2021-11-08 2023-05-12 黑龙江珍宝岛药业股份有限公司 Method for establishing lignan component fingerprint of ginkgo leaf extraction intermediate or ginkgo leaf preparation and application thereof
CN115006435B (en) * 2022-06-21 2023-11-28 浙江康恩贝制药股份有限公司 Ginkgo leaf organic acid extract and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102199159B (en) * 2011-03-21 2013-07-03 贵州大学 Method for separating and purifying ginkgolide C in ginkgo root bark
CN102174052B (en) * 2011-03-23 2014-10-01 晨光生物科技集团天津有限公司 Method for extracting and refining ginkgolide
CN103610708B (en) * 2013-11-19 2016-08-17 浙江康恩贝制药股份有限公司 The preparation technology of low acid high-purity terpene lactones extract in a kind of Cortex Ginkgo

Also Published As

Publication number Publication date
GB2597145A (en) 2022-01-19
CN111747914A (en) 2020-10-09
CN111747914B (en) 2023-01-13
WO2020199568A1 (en) 2020-10-08
GB2597145B (en) 2022-06-15

Similar Documents

Publication Publication Date Title
IL304526A (en) Manufacture of compounds and compositions for inhibiting the activity of shp2
EP3677584A4 (en) Compound having bruton's tyrosine kinase (btk)-inhibition and degradation activity
GB201720163D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
SG11202107325TA (en) Methods and compositions for the treatment of fabry disease
IL288278A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
IL281015A (en) Methods and compositions for the modification of plants
IL266047A (en) Methods and compositions for the treatment of fabry disease
ZA201903475B (en) Extract of an herbal composition as antimicrobial and/or antibiofilm agent
GB2597145B (en) Compound separated from root bark of Ginkgo biloba and use thereof
WO2014136993A3 (en) Skin care cosmetic
EP4218736A3 (en) Compositions comprising 15-hepe
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
IL288695A (en) Compounds extracted from plant matter and methods of preparation thereof
EP4069215A4 (en) Topical compositions containing rose oil and cannabidiol and methods of making and using the same
IL275573A (en) Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza
IL286697A (en) Neuregulin-4 compounds and methods of use
SG11202111701XA (en) Coated drug compositions and methods of preparing the same
SG11202011227VA (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
EP3413904A4 (en) Herbal compositions and methods for the prevention and treatment of plant or nail infections
MX355146B (en) Tooth varnish compositions and methods for their use.
SG11202011041YA (en) Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof
MY181719A (en) Fragrance and flavor compositions comprising neopentyl glycol diacetate
EP3740592A4 (en) Methods and compositions for the treatment of vascular disease
EP3804728A4 (en) Composition comprising inotodiol compound as effective ingredient for prevention or treatment of allergy disease
IL290902A (en) The compounds to identify beta-lactamases, and methods of use thereof